Cargando…
Mutations in membrane cofactor protein (CD46) gene in Indian children with hemolytic uremic syndrome
BACKGROUND: Mutations in the CD46 gene account for an important proportion of patients with atypical hemolytic uremic syndrome (aHUS) who characteristically show multiple relapses, no response to plasma exchange and low recurrence risk in allograft. We screened for mutations in CD46 in patients with...
Autores principales: | Khandelwal, Priyanka, Birla, Shweta, Bhatia, Divya, Puraswani, Mamta, Saini, Himanshi, Sinha, Aditi, Hari, Pankaj, Sharma, Arundhati, Bagga, Arvind |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5888602/ https://www.ncbi.nlm.nih.gov/pubmed/29644059 http://dx.doi.org/10.1093/ckj/sfx078 |
Ejemplares similares
-
Clinical and Immunological Profile of Anti-factor H Antibody Associated Atypical Hemolytic Uremic Syndrome: A Nationwide Database
por: Puraswani, Mamta, et al.
Publicado: (2019) -
Anti-factor H antibody associated hemolytic uremic syndrome following SARS-CoV-2 infection
por: Khandelwal, Priyanka, et al.
Publicado: (2022) -
Efficacy of rituximab versus tacrolimus in difficult-to-treat steroid-sensitive nephrotic syndrome: an open-label pilot randomized controlled trial
por: Mathew, Georgie, et al.
Publicado: (2022) -
Optimal management of atypical hemolytic uremic disease: challenges and solutions
por: Raina, Rupesh, et al.
Publicado: (2019) -
Pediatric Atypical Hemolytic Uremic Syndrome Advances
por: Raina, Rupesh, et al.
Publicado: (2021)